Comment on Mayock SP, Saim S, Fleming AB. In Vitro Drug Release After Crushing: Evaluation of Xtampza(®) ER and Other ER Opioid Formulations

Lignende værker

• Response to Crudele et al. Commentary on Mayock et al. “In Vitro Drug Release after Crushing: Evaluation of Xtampza(®) ER and Other ER Opioid Formulations”
  af: Fleming, Alison B., et al.
  Udgivet: (2018)
• In Vitro Drug Release After Crushing: Evaluation of Xtampza(®) ER and Other ER Opioid Formulations
  af: Mayock, Stephen P., et al.
  Udgivet: (2017)
• Author Correction to: In Vitro Drug Release After Crushing: Evaluation of Xtampza(®) ER and Other ER Opioid Formulations
  af: Mayock, Stephen P., et al.
  Udgivet: (2017)
• Postmarketing Analysis of Misuse, Abuse, and Diversion of Xtampza ER
  af: Geoffrey Severtson, Stevan, et al.
  Udgivet: (2020)
• Assessment of a formulation designed to be crush-resistant in prescription opioid abusers
  af: Vosburg, Suzanne K., et al.
  Udgivet: (2012)